Total Payments
$32,598
2024 Payments
$1,955
Companies
29
Transactions
558
Medicare Patients
11,065
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$18,000 (55.2%)
Food & Beverage$13,003 (39.9%)
Consulting$1,000 (3.1%)
Travel$572.17 (1.8%)
Education$23.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,000 | 8 | 55.2% |
| Food and Beverage | $13,003 | 542 | 39.9% |
| Consulting Fee | $1,000 | 4 | 3.1% |
| Travel and Lodging | $572.17 | 1 | 1.8% |
| Education | $23.25 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $19,237 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,471 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,100 | 66 | $0 (2024) |
| Amgen Inc. | $1,496 | 53 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,471 | 37 | $0 (2024) |
| Boston Scientific Corporation | $1,450 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $825.71 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $702.31 | 59 | $0 (2024) |
| Esperion Therapeutics, Inc. | $639.64 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $303.78 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,955 | 83 | AstraZeneca Pharmaceuticals LP ($581.22) |
| 2023 | $1,401 | 58 | AstraZeneca Pharmaceuticals LP ($463.58) |
| 2022 | $1,348 | 65 | Janssen Pharmaceuticals, Inc ($212.38) |
| 2021 | $1,886 | 62 | Boehringer Ingelheim Pharmaceuticals, Inc. ($503.99) |
| 2020 | $1,414 | 54 | Amgen Inc. ($418.71) |
| 2019 | $1,645 | 80 | Boehringer Ingelheim Pharmaceuticals, Inc. ($351.89) |
| 2018 | $7,872 | 89 | PFIZER INC. ($4,638) |
| 2017 | $15,078 | 67 | PFIZER INC. ($13,720) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.28 | General |
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: DIABETES | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 08/19/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $18.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,834 | 5,275 | $1.3M | $460,591 |
| 2022 | 19 | 2,172 | 4,744 | $950,368 | $363,288 |
| 2021 | 24 | 2,980 | 6,039 | $1.3M | $488,426 |
| 2020 | 28 | 3,079 | 6,341 | $1.3M | $463,305 |
Total Patients
11,065
Total Services
22,399
Medicare Billing
$1.8M
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 671 | 1,854 | $370,800 | $167,693 | 45.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 265 | 266 | $202,725 | $86,721 | 42.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 307 | 312 | $182,520 | $44,386 | 24.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 208 | 830 | $51,187 | $36,929 | 72.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 162 | 165 | $82,500 | $23,372 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 140 | 174 | $42,630 | $22,538 | 52.9% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 63 | 64 | $41,600 | $17,330 | 41.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 263 | 270 | $95,526 | $14,018 | 14.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 267 | 268 | $98,790 | $12,815 | 13.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $19,600 | $8,691 | 44.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 26 | 26 | $9,100 | $4,746 | 52.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 29 | 29 | $10,150 | $4,073 | 40.1% |
| A9512 | Technetium tc-99m pertechnetate, diagnostic, per millicurie | Office | 2023 | 61 | 62 | $5,110 | $3,457 | 67.7% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 20 | 21 | $8,012 | $2,708 | 33.8% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 23 | 24 | $5,243 | $2,123 | 40.5% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 50 | 395 | $9,579 | $2,015 | 21.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 24 | 35 | $3,850 | $1,827 | 47.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 125 | 147 | $12,348 | $1,562 | 12.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 16 | 87 | $3,045 | $1,320 | 43.4% |
| 93291 | Evaluation of cardiac rhythm monitor system | Office | 2023 | 11 | 31 | $3,720 | $1,101 | 29.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 18 | 119 | $2,410 | $499.80 | 20.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 18 | 27 | $2,970 | $491.91 | 16.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 11 | 13 | $1,235 | $169.90 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 713 | 1,838 | $367,600 | $168,584 | 45.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 162 | 162 | $123,930 | $56,537 | 45.6% |
About Dr. Devendra Amin, MD
Dr. Devendra Amin, MD is a Specialist healthcare provider based in Easton, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760452973.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devendra Amin, MD has received a total of $32,598 in payments from pharmaceutical and medical device companies, with $1,955 received in 2024. These payments were reported across 558 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,000).
As a Medicare-enrolled provider, Amin has provided services to 11,065 Medicare beneficiaries, totaling 22,399 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Specialist
- Location Easton, PA
- Active Since 01/23/2006
- Last Updated 03/15/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1760452973
Products in Payments
- ELIQUIS (Drug) $20,523
- JARDIANCE (Drug) $2,118
- GENERAL THERAPIES (Device) $1,242
- Repatha (Biological) $1,022
- XARELTO (Drug) $825.71
- BRILINTA (Drug) $800.69
- FARXIGA (Drug) $526.21
- ENTRESTO (Drug) $484.97
- Corlanor (Drug) $464.04
- NEXLETOL (Drug) $390.64
- PRADAXA (Drug) $352.68
- VERQUVO (Drug) $285.55
- PRALUENT (Drug) $266.38
- NEXLIZET (Drug) $249.00
- WAINUA (Drug) $241.85
- Kerendia (Drug) $232.74
- LOKELMA (Drug) $223.54
- Livalo (Drug) $218.30
- LEQVIO (Drug) $198.22
- ZONTIVITY (Drug) $187.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Easton
Donald Stranahan, Md, MD
Specialist — Payments: $11,718
Specialist $11,718
Dr. Michael Del Torto, M.d, M.D
Specialist — Payments: $11,399
Specialist $11,399
Dr. David Oliver, M.d, M.D
Specialist — Payments: $6,766
Specialist $6,766
John Condit, D.o, D.O
Specialist — Payments: $4,812
Specialist $4,812
Dr. Barry Herman, M.d, M.D
Specialist — Payments: $3,110
Specialist $3,110
Dr. Timothy Shanahan, D.o, D.O
Specialist — Payments: $2,989
Specialist $2,989